Alector (ALEC) announced that its CFO, Marc Grasso, M.D., will conclude his tenure with the company, effective June 20 to pursue other opportunities. Neil Berkley the company’s Chief Business Officer, will assume the role of Interim CFO while continuing in his current position.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALEC:
- Alector Reports Increased Loss, Advances Clinical Pipeline
- Alector price target raised to $10 from $7 at H.C. Wainwright
- Alector’s Growth Potential Highlighted by Strong Financials and Promising Trial Developments
- Alector’s Clinical Progress and Financial Stability Drive Buy Rating
- Alector reports Q1 EPS (41c), consensus (46c)